CARLCarlsmed Inc
Slide 1 of 3
Company Overview
Name
Carlsmed Inc
52W High
$16.20
52W Low
$11.70
Market Cap
$249.6M
Dividend Yield
0%
Price/earnings
-0.4
P/E
-0.4
Dividends
No dividend
Sentiment
Score
Very Bullish
85
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$13.1M
Operating Revenue
$13.1M
Total Gross Profit
$9.9M
Total Operating Income
$-9M
Net Income
$-8.5M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.00
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$4.9M
Marketing Expense
$9.6M
Research & Development Expense
$4.4M
Total Operating Expenses
$-19M
Interest Expense
$-380K
Interest & Investment Income
$1M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Carlsmed Inc
52W High
$16.20
52W Low
$11.70
Market Cap
$249.6M
Dividend Yield
0%
Price/earnings
-0.4
P/E
-0.4
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Very Bullish
85
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$13.1M
Operating Revenue
$13.1M
Total Gross Profit
$9.9M
Total Operating Income
$-9M
Net Income
$-8.5M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.00
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$4.9M
Marketing Expense
$9.6M
Research & Development Expense
$4.4M
Total Operating Expenses
$-19M
Interest Expense
$-380K
Interest & Investment Income
$1M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Michael Cordonnier
Location
California, USA
Exchange
Nasdaq
Website
https://carlsmed.com/
Summary
We are a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Company Info
CEO
Michael Cordonnier
Location
California, USA
Exchange
Nasdaq
Website
https://carlsmed.com/
Summary
We are a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
